On January 2, 2020 Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) reported that February 2020 (Press release, Evotec, JAN 2, 2020, View Source;announcements/press-releases/p/evotec-to-attend-upcoming-investor-conferences-5889 [SID1234552656]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
ODDO BHF Forum 2020, Lyon, France
Date: Thursday, 09 January 2020 to Friday, 10 January 2020
Venue: Lyon, France
Attendee: Enno Spillner, Chief Financial Officer
38th J.P. Morgan Healthcare Conference, San Francisco, USA
Date: Monday, 13 January 2020 to Thursday, 16 January 2020, Presentation: 16 January 2020, 11.00 am PT (2.00 pm EST, 7.00 pm GMT, 8.00 pm CET)
Webcast: Click here for the webcast
Venue: San Francisco, USA
Attendee: Dr Werner Lanthaler, Chief Executive Officer
19th German Corporate Conference 2020, jointly hosted by UniCredit and Kepler Cheuvreux, Frankfurt am Main, Germany
Date: Tuesday, 21 January 2020, Presentation: 21 January 2020, 4.00 pm CET
Venue: Frankfurt am Main, Germany
Attendee: Dr Werner Lanthaler, Chief Executive Officer
Bankhaus Lampe German Equity Forum, London, UK
Date: Thursday, 30 January 2020
Venue: London, UK
Attendee: Dr Werner Lanthaler, Chief Executive Officer
8th Business Forum of LBBW (8. Unternehmensforum der LBBW)
Date: Thursday, 13 February 2020
Venue: Stuttgart, Germany
Attendee: Enno Spillner, Chief Financial Officer